US Stock MarketDetailed Quotes

ASLN Aslan Pharmaceuticals

Watchlist

0.6000
0.00000.00%

Close Jul 18 16:00 ET

1.70MMarket Cap-38P/E (TTM)

Aslan Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(FY)Dec 31, 2018

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-21.44%-46.64M

-12.97%-38.41M

-125.84%-34M

41.66%-15.05M

0.45%-5.04M

74.93%-1.77M

34.63%-25.8M

-5.06M

32.99%-7.05M

-15.69%-39.47M

Net income from continuing operations

14.03%-44.09M

-62.34%-51.28M

-86.14%-31.59M

63.63%-16.97M

79.88%-5.95M

29.82%-3.7M

-10.64%-46.66M

---29.59M

55.61%-5.26M

-5.71%-42.17M

Operating gains losses

-60.42%207.28K

124.56%523.73K

-1,137.84%-2.13M

-1.93%205.49K

34.19%369.06K

204.27%226.85K

147.18%209.54K

--275.02K

4.03%-217.56K

-160.85%-444.16K

Depreciation and amortization

5.05%348.5K

17.55%331.75K

-5.22%282.22K

-33.14%297.76K

-14.32%72.75K

-29.04%74K

84.21%445.35K

--84.91K

59.77%104.29K

15.14%241.77K

Other non cash items

20.09%3.93M

75.72%3.27M

49.25%1.86M

52.92%1.25M

21.56%348.78K

6.85%220.54K

264.66%815.29K

--286.92K

3,306.94%206.39K

317.42%223.57K

Change In working capital

-131.56%-2.95M

326.94%9.35M

-4,122.55%-4.12M

97.20%-97.59K

-107.83%-42.81K

191.62%1.46M

-391.27%-3.49M

--546.82K

-461.53%-1.6M

-63.64%1.2M

-Change in receivables

----

--0

-Change in prepaid assets

----

-3,247.78%-46.78K

----

-97.31%1.49K

-733.10%-111.65K

-Change in payables and accrued expense

-141.71%-4.05M

813.53%9.71M

-255.77%-1.36M

124.26%873.54K

230.25%1.56M

137.86%605.75K

-375.18%-3.6M

--472.62K

-513.54%-1.6M

-33.92%1.31M

-Change in other current assets

406.91%1.1M

85.63%-357.72K

-156.42%-2.49M

-946.84%-971.13K

----

--114.68K

----

-Change in other current liabilities

--0

---269.74K

--0

---918.15K

----

Cash from discontinued investing activities

Operating cash flow

-21.44%-46.64M

-12.97%-38.41M

-125.84%-34M

41.66%-15.05M

0.45%-5.04M

74.93%-1.77M

34.63%-25.8M

---5.06M

32.99%-7.05M

-15.69%-39.47M

Investing cash flow

Cash flow from continuing investing activities

-35.25%268.52K

1,572.91%414.7K

-3,137.22%-28.16K

-82.77%927

298.49%6.09K

-115.03%-5.52K

100.02%5.38K

1.53K

104.04%36.73K

-6,764.23%-23.09M

Net PPE purchase and sale

59.01%-10.63K

28.83%-25.94K

-848.67%-36.45K

-235.57%-3.84K

-44.01%855

-596.17%-5.06K

103.53%2.83K

--1.53K

103.67%1.02K

72.46%-80.26K

Net intangibles purchase and sale

--0

---12.36K

--0

----

-259,996.05%-23M

Net investment purchase and sale

--0

--87.49K

--0

----

Net other investing changes

----

333.07%20.65K

87.31%4.77K

523,300.00%5.23K

----

122.87%2.55K

--1

164.67%35.71K

69.22%-11.13K

Cash from discontinued investing activities

Investing cash flow

-35.25%268.52K

1,572.91%414.7K

-3,137.22%-28.16K

-82.77%927

298.49%6.09K

-115.03%-5.52K

100.02%5.38K

--1.53K

104.04%36.73K

-6,764.23%-23.09M

Financing cash flow

Cash flow from continuing financing activities

126.90%10.72M

-95.70%4.72M

1,431.59%109.87M

-62.43%7.17M

-62.13%7.3M

111.88%5.29K

-53.32%19.09M

19.27M

-105.26%-44.55K

22.86%40.9M

Net issuance payments of debt

-359.58%-12.3M

-60.06%4.74M

5,954.87%11.86M

-106.74%-202.61K

-102.47%-78.53K

111.88%5.29K

-25.95%3.01M

--3.19M

---44.55K

1,676.85%4.06M

Net common stock issuance

--7.68M

--0

1,228.70%101.56M

-48.12%7.64M

----

-65.07%14.73M

----

27.58%42.18M

Cash dividends paid

--0

----

--0

Proceeds from stock option exercised by employees

--15.44M

--0

--1.05M

--0

----

-50.00%24K

----

--48K

Net other financing activities

---93.81K

----

-1,895.96%-4.58M

-117.27%-229.3K

----

124.64%1.33M

----

---5.39M

Cash from discontinued financing activities

Financing cash flow

126.90%10.72M

-95.70%4.72M

1,431.59%109.87M

-62.43%7.17M

-62.13%7.3M

111.88%5.29K

-53.32%19.09M

--19.27M

-105.26%-44.55K

22.86%40.9M

Net cash flow

Beginning cash position

-36.89%56.9M

529.47%90.17M

-35.48%14.32M

-23.20%22.2M

50.88%12.06M

-8.12%13.83M

-42.84%28.91M

--7.99M

-66.37%15.05M

-2.25%50.57M

Current changes in cash

-7.17%-35.65M

-143.86%-33.27M

1,062.65%75.84M

-17.49%-7.88M

-84.07%2.26M

74.96%-1.77M

69.05%-6.71M

--14.21M

33.31%-7.06M

-1,761.46%-21.66M

End cash Position

-62.65%21.25M

-36.89%56.9M

529.47%90.17M

-35.48%14.32M

50.88%12.06M

-23.20%22.2M

--22.2M

-77.03%7.99M

-42.84%28.91M

Free cash flow

-21.38%-46.65M

-12.89%-38.43M

-126.09%-34.04M

41.65%-15.06M

0.45%-5.04M

74.86%-1.77M

58.75%-25.81M

---5.06M

37.69%-7.05M

-81.75%-62.55M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(FY)Dec 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-21.44%-46.64M	-12.97%-38.41M	-125.84%-34M	41.66%-15.05M	0.45%-5.04M	74.93%-1.77M	34.63%-25.8M	-5.06M	32.99%-7.05M	-15.69%-39.47M
Net income from continuing operations	14.03%-44.09M	-62.34%-51.28M	-86.14%-31.59M	63.63%-16.97M	79.88%-5.95M	29.82%-3.7M	-10.64%-46.66M	---29.59M	55.61%-5.26M	-5.71%-42.17M
Operating gains losses	-60.42%207.28K	124.56%523.73K	-1,137.84%-2.13M	-1.93%205.49K	34.19%369.06K	204.27%226.85K	147.18%209.54K	--275.02K	4.03%-217.56K	-160.85%-444.16K
Depreciation and amortization	5.05%348.5K	17.55%331.75K	-5.22%282.22K	-33.14%297.76K	-14.32%72.75K	-29.04%74K	84.21%445.35K	--84.91K	59.77%104.29K	15.14%241.77K
Other non cash items	20.09%3.93M	75.72%3.27M	49.25%1.86M	52.92%1.25M	21.56%348.78K	6.85%220.54K	264.66%815.29K	--286.92K	3,306.94%206.39K	317.42%223.57K
Change In working capital	-131.56%-2.95M	326.94%9.35M	-4,122.55%-4.12M	97.20%-97.59K	-107.83%-42.81K	191.62%1.46M	-391.27%-3.49M	--546.82K	-461.53%-1.6M	-63.64%1.2M
-Change in receivables	----	----	----	----	----	----	----	----	----	--0
-Change in prepaid assets	----	----	----	----	----	-3,247.78%-46.78K	----	----	-97.31%1.49K	-733.10%-111.65K
-Change in payables and accrued expense	-141.71%-4.05M	813.53%9.71M	-255.77%-1.36M	124.26%873.54K	230.25%1.56M	137.86%605.75K	-375.18%-3.6M	--472.62K	-513.54%-1.6M	-33.92%1.31M
-Change in other current assets	406.91%1.1M	85.63%-357.72K	-156.42%-2.49M	-946.84%-971.13K	----	----	--114.68K	----	----	----
-Change in other current liabilities	--0	--0	---269.74K	--0	---918.15K	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-21.44%-46.64M	-12.97%-38.41M	-125.84%-34M	41.66%-15.05M	0.45%-5.04M	74.93%-1.77M	34.63%-25.8M	---5.06M	32.99%-7.05M	-15.69%-39.47M
Investing cash flow
Cash flow from continuing investing activities	-35.25%268.52K	1,572.91%414.7K	-3,137.22%-28.16K	-82.77%927	298.49%6.09K	-115.03%-5.52K	100.02%5.38K	1.53K	104.04%36.73K	-6,764.23%-23.09M
Net PPE purchase and sale	59.01%-10.63K	28.83%-25.94K	-848.67%-36.45K	-235.57%-3.84K	-44.01%855	-596.17%-5.06K	103.53%2.83K	--1.53K	103.67%1.02K	72.46%-80.26K
Net intangibles purchase and sale	--0	--0	---12.36K	--0	----	----	----	----	----	-259,996.05%-23M
Net investment purchase and sale	--0	--87.49K	--0	--0	----	----	----	----	----	----
Net other investing changes	----	----	333.07%20.65K	87.31%4.77K	523,300.00%5.23K	----	122.87%2.55K	--1	164.67%35.71K	69.22%-11.13K
Cash from discontinued investing activities
Investing cash flow	-35.25%268.52K	1,572.91%414.7K	-3,137.22%-28.16K	-82.77%927	298.49%6.09K	-115.03%-5.52K	100.02%5.38K	--1.53K	104.04%36.73K	-6,764.23%-23.09M
Financing cash flow
Cash flow from continuing financing activities	126.90%10.72M	-95.70%4.72M	1,431.59%109.87M	-62.43%7.17M	-62.13%7.3M	111.88%5.29K	-53.32%19.09M	19.27M	-105.26%-44.55K	22.86%40.9M
Net issuance payments of debt	-359.58%-12.3M	-60.06%4.74M	5,954.87%11.86M	-106.74%-202.61K	-102.47%-78.53K	111.88%5.29K	-25.95%3.01M	--3.19M	---44.55K	1,676.85%4.06M
Net common stock issuance	--7.68M	--0	1,228.70%101.56M	-48.12%7.64M	----	----	-65.07%14.73M	----	----	27.58%42.18M
Cash dividends paid	--0	--0	--0	--0	----	----	----	----	----	--0
Proceeds from stock option exercised by employees	--15.44M	--0	--1.05M	--0	----	----	-50.00%24K	----	----	--48K
Net other financing activities	---93.81K	----	-1,895.96%-4.58M	-117.27%-229.3K	----	----	124.64%1.33M	----	----	---5.39M
Cash from discontinued financing activities
Financing cash flow	126.90%10.72M	-95.70%4.72M	1,431.59%109.87M	-62.43%7.17M	-62.13%7.3M	111.88%5.29K	-53.32%19.09M	--19.27M	-105.26%-44.55K	22.86%40.9M
Net cash flow
Beginning cash position	-36.89%56.9M	529.47%90.17M	-35.48%14.32M	-23.20%22.2M	50.88%12.06M	-8.12%13.83M	-42.84%28.91M	--7.99M	-66.37%15.05M	-2.25%50.57M
Current changes in cash	-7.17%-35.65M	-143.86%-33.27M	1,062.65%75.84M	-17.49%-7.88M	-84.07%2.26M	74.96%-1.77M	69.05%-6.71M	--14.21M	33.31%-7.06M	-1,761.46%-21.66M
End cash Position	-62.65%21.25M	-36.89%56.9M	529.47%90.17M	-35.48%14.32M	-35.48%14.32M	50.88%12.06M	-23.20%22.2M	--22.2M	-77.03%7.99M	-42.84%28.91M
Free cash flow	-21.38%-46.65M	-12.89%-38.43M	-126.09%-34.04M	41.65%-15.06M	0.45%-5.04M	74.86%-1.77M	58.75%-25.81M	---5.06M	37.69%-7.05M	-81.75%-62.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--	Unqualified Opinion	--	--	Unqualified Opinion

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data